Daniela Weiskopf

Citée par

	Toutes	Depuis 2020
Citations	34837	29781
indice h	72	62
indice i10	144	142

9000

4500

2250

6750

2010201120122013201420152016201720182019202020212022202320242025129 182 196 260 718 397 466 631 860 987 2703 6978 8719 6210 4450 516

Accès public

Tout afficher

194 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Alessandro SetteAdresse e-mail validée de liai.org
Alba GrifoniResearch Assistant Professor, La Jolla Institute for immunologyAdresse e-mail validée de lji.org
Bjoern PetersProfessor at La Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
Shane CrottyProfessor and CSO, La Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
John SidneyLa Jolla Institute for AllergyAdresse e-mail validée de lji.org
Jennifer DanAdresse e-mail validée de lji.org
Jose MateusScientist, Vividion TherapeuticsAdresse e-mail validée de vividion.com
Aruna Dharshan De SilvaProfessor, Faculty of Medicine, General Sir John Kotelawala Defence University, Sri LankaAdresse e-mail validée de kdu.ac.lk
Ricardo da Silva AntunesLa Jolla Institute for Allergy and ImmunologyAdresse e-mail validée de lji.org
Sydney Ilima RamirezUC San Diego, La Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
Stephen Arthur RawlingsInfectious Diseases Physician, Maine Medical CenterAdresse e-mail validée de mainehealth.org
Davey SmithProfessor of Medicine, University of California, San DiegoAdresse e-mail validée de ucsd.edu
Esther Dawen YuLa Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
Simon MallalDirector, Institute for Immunology and Infectious Diseases, Murdoch University, Western AustraliaAdresse e-mail validée de iiid.com.au
Cecilia Lindestam ArlehamnLa Jolla Institute for Allergy and ImmunologyAdresse e-mail validée de liai.org
Florian KrammerIcahn School of Medicine at Mount SinaiAdresse e-mail validée de mssm.edu
Michael A. AngeloBristol Myers SquibbAdresse e-mail validée de bms.com
Gregory SeumoisResearch Assistant Professor, La Jolla Institute for ImmunologyAdresse e-mail validée de lji.org
Sinu PaulBioinformatics Scientist, Rancho BiosciencesAdresse e-mail validée de ranchobiosciences.com
Pandurangan VijayanandProfessor, La Jolla Institute for ImmunologyAdresse e-mail validée de lji.org

Suivre

Daniela Weiskopf

La Jolla Institute for Immunology

Adresse e-mail validée de lji.org - Page d'accueil

Immunology T cells MHC infectious diseases


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ... Cell 181 (7), 1489-1501. e15, 2020	4241	2020
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ... Science 371 (6529), eabf4063, 2021	3099	2021
Induction of autophagy by spermidine promotes longevity T Eisenberg, H Knauer, A Schauer, S Büttner, C Ruckenstuhl, ... Nature cell biology 11 (11), 1305-1314, 2009	2148	2009
Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020	1952	2020
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020	1249	2020
The aging of the immune system D Weiskopf, B Weinberger, B Grubeck‐Loebenstein Transplant international 22 (11), 1041-1050, 2009	1045	2009
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome D Weiskopf, KS Schmitz, MP Raadsen, A Grifoni, NMA Okba, H Endeman, ... Science immunology 5 (48), eabd2071, 2020	1017	2020
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020	952	2020
Properties of MHC class I presented peptides that enhance immunogenicity JJA Calis, M Maybeno, JA Greenbaum, D Weiskopf, AD De Silva, A Sette, ... PLoS computational biology 9 (10), e1003266, 2013	912	2013
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021	844	2021
T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017	826	2017
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022	792	2022
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells D Weiskopf, MA Angelo, EL de Azeredo, J Sidney, JA Greenbaum, ... Proceedings of the National Academy of Sciences 110 (22), E2046-E2053, 2013	660	2013
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals A Tarke, J Sidney, N Methot, ED Yu, Y Zhang, JM Dan, B Goodwin, ... Cell Reports Medicine 2 (7), 2021	587	2021
T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022	577	2022
A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020	566	2020
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021	557	2021
Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19 BJ Meckiff, C Ramírez-Suástegui, V Fajardo, SJ Chee, A Kusnadi, ... Cell 183 (5), 1340-1353. e16, 2020	543	2020
Biology of immune responses to vaccines in elderly persons B Weinberger, D Herndler-Brandstetter, A Schwanninger, D Weiskopf, ... Clinical Infectious Diseases 46 (7), 1078-1084, 2008	525	2008
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, ... Nature medicine 27 (11), 1990-2001, 2021	489	2021

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs